AzTrials
AzTrials

DeliriumUNDERPIN-ICUNCT03002701

The Impact of Nursing Delirium Preventive Interventions in the Intensive Care Unit

A study testing UNDERPIN-ICU program in people with Delirium, run by Radboud University Medical Center at 11 sites in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated with serious short- and long-term consequences. This study focuses on a program of standardized nursing and physical therapy interventions to prevent delirium in the ICU, and determines the effect of the program on the number of… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Delirium
What is being tested?
UNDERPIN-ICU program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,750 participants
Where
11 sitesNetherlands
Study dates
31 Dec 2016to 31 May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged ≥ 18 years
  • surgical, medical or trauma patients
  • admitted to one of the participating ICUs
  • at high risk for delirium (>35% determined with the E-PRE-DELIRIC prediction tool)

Who cannot join

  • delirious before ICU admission
  • an ICU stay < one day
  • reliable assessment for delirium is not possible due to: sustained coma; serious auditory or visual disorders; inability to understand Dutch; severely mentally disabled; serious receptive aphasia.

Trial locations and contacts

11 sites in 1 country.

11 sites in 1 country

Netherlands11 sites
  • Hospital Gelderse Vallei

    Ede

  • Medical Spectrum Twente

    Enschede

  • Hospital St. Jansdal

    Harderwijk

  • Medical Center Leeuwarden

    Leeuwarden

  • Radboud University Medical Center

    Nijmegen, Gelderland, 6500HB

  • Haaglanden Medical Center location Westeinde

    The Hague

  • Hospital ETZ location Elisabeth

    Tilburg

  • Hospital ETZ location Tweesteden

    Tilburg

  • Bernhoven Hospital

    Uden

  • Maxima Medical Center

    Veldhoven

  • ISALA clinics

    Zwolle

Other trials in Netherlands

About this study

Official title: The Impact of nUrsiNg DEliRium Preventive INterventions in the Intensive Care Unit (UNDERPIN-ICU): A Multi-centre, Stepped Wedge Randomized Controlled Trial

Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated with serious short- and long-term consequences. This study focuses on a program of standardized nursing and physical therapy interventions to prevent delirium in the ICU, and determines the effect of the program on the number of delirium-coma-free days in 28 days and several secondary outcomes in a multicenter randomized controlled trial.

Read the detailed description

Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated with serious short- and long-term consequences, including re-intubations, ICU readmissions, prolonged ICU and hospital stay, persistent cognitive problems, and higher mortality rates. Considering the high incidence of delirium and its consequences, prevention of delirium is imperative. This study focuses on a program of standardized nursing and physical therapy interventions to prevent delirium in the ICU, called UNDERPIN-ICU (nUrsiNg DEliRium Preventive INterventions in the ICU).

Objective: To determine the effect of the UNDERPIN-ICU program on the number of delirium-coma-free days in 28 days and several secondary outcomes, such as delirium incidence, the number of days of survival in 28 and 90 days and delirium-related outcomes.

Design and Setting: A multicenter stepped wedge cluster randomized controlled trial.

Methods: Eight to ten Dutch ICUs will implement the UNDERPIN-ICU program in a randomized order. Every two months the UNDERPIN-ICU program will be implemented in an additional ICU following a two months period of staff training. UNDERPIN-ICU consists of standardized protocols focusing on several modifiable risk factors for delirium, including cognitive impairment, sleep deprivation, immobility and visual and hearing impairment.

Participants: ICU patients aged ≥ 18 years (surgical, medical, or trauma) and at high risk for delirium, E-PRE-DELIRIC ≥35%, will be included, unless delirium was detected prior ICU admission, expected length of ICU stay is less then one day or when delirium assessment is not possible.

Conditions
Delirium
Being tested
UNDERPIN-ICU program
Keywords
Prevention, Critical care, Delirium, Nurse, RCT
Medical subject headings
Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UNDERPIN-ICU programBehavioural

    UNDERPIN-ICU consists of standardized protocols focusing on several modifiable risk factors for delirium, including cognitive impairment, sleep deprivation, immobility and visual and hearing impairment.

Study groups in NCT03002701
Study groupRoleWhat they receive
Control - standard careNo interventionPrior to implementation of the intervention package the current standard of care will be maintained.
Intervention groupActive comparatorAfter implementation the intervention package will be implemented as standard care.
Receives: Behavioral: UNDERPIN-ICU program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of delirium-coma-free days

    The number of days a patient is not delirious and not in coma in 28 days starting from the day of inclusion in the study after ICU admission.

    Measured: 28 days

Secondary outcomes (14)
  1. Delirium incidence

    One or more episodes of positive delirium screening after ICU admission.

    Measured: 28 days

  2. The number of days of survival

    The number of days survived since ICU admission.

    Measured: 28 days

  3. The number of days of survival

    The number of days survived since ICU admission.

    Measured: 90 days

  4. Duration of mechanical ventilation

    The number of days a patient was mechanically ventilated.

    Measured: 28 days

  5. Incidence of re-intubation

    Patients who need to be intubated within 28 days after ICU admission, following a previous extubation, irrespectively the reason for re-intubation, will be counted as incident case for re-intubation.

    Measured: 28 days

  6. Incidence of ICU re-admission

    Patients who need to be readmitted to the ICU within 28 days, irrespectively the reason for readmission, will be counted as incident cases for ICU readmission.

    Measured: 28 days

  7. Incidence of unplanned removal of tubes/catheters

    Incidents in which patients remove their tube or catheter themselves will be counted as incident cases for unplanned removal. The period in which this is measured is during patients' ICU stay or during the period when the patient is delirious (in case a patient is discharged to the ward) with a maximum of 28 days.

    Measured: 28 days

  8. Incidence of physical restraints

    Patients who need physical restraints (fixation of their limbs to prevent them from removing tubes or lines) within 28 days, will be counted as incident cases for physical restraints.

    Measured: 28 days

  9. ICU length of stay

    This is defined as the number of days a patient is admitted to the ICU. Hospital length of stay is defined as number of days a patient is admitted to the hospital.

    Measured: 365 days

  10. Hospital length of stay

    This is defined as the number of days a patient is admitted to the ICU. Hospital length of stay is defined as number of days a patient is admitted to the hospital.

    Measured: 365 days

  11. Health related quality of Life (HRQoL)

    Measured: 90 days after ICU admission

  12. Health related quality of Life (HRQoL)

    Measured: 365 days after ICU admission

  13. Post-hoc analysis

    Measured: During admission

  14. Cost-effectiveness

    Measured: During ICU admission

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2016 (estimated)
  2. Study start31 Dec 2016
  3. Primary completion31 May 2019
  4. Study completion31 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
1,750 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03002701
Sponsor's protocol ID
UNDERPIN-ICU
Acronym
UNDERPIN-ICU
Status last verified
Oct 2020
First submitted
25 Nov 2016
Last updated
9 Oct 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Wassenaar A, Rood P, Schoonhoven L, Teerenstra S, Zegers M, Pickkers P, van den Boogaard M. The impact of nUrsiNg DEliRium Preventive INnterventions in the Intensive Care Unit (UNDERPIN-ICU): A study protocol for a multi-centre, stepped wedge randomized controlled trial. Int J Nurs Stud. 2017 Mar;68:1-8. doi: 10.1016/j.ijnurstu.2016.11.018. Epub 2016 Dec 8.

    PubMed 28013104
  • Tilburgs B, Rood PJT, Zegers M, van den Boogaard M; UNDERPIN-ICU study group. The implementation of nUrsiNg DEliRium preventive INterventions in the Intensive Care Unit (UNDERPIN-ICU): A qualitative evaluation. Int J Nurs Stud. 2023 Jan;137:104386. doi: 10.1016/j.ijnurstu.2022.104386. Epub 2022 Nov 8.

    PubMed 36427481
  • Rood PJT, Zegers M, Ramnarain D, Koopmans M, Klarenbeek T, Ewalds E, van der Steen MS, Oldenbeuving AW, Kuiper MA, Teerenstra S, Adang E, van Loon LM, Wassenaar A, Vermeulen H, Pickkers P, van den Boogaard M; UNDERPIN-ICU Study Investigators. The Impact of Nursing Delirium Preventive Interventions in the ICU: A Multicenter Cluster-randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2021 Sep 15;204(6):682-691. doi: 10.1164/rccm.202101-0082OC.

    PubMed 34170798

Questions about this trial

What is this clinical trial studying?

A study testing UNDERPIN-ICU program in people with Delirium, run by Radboud University Medical Center at 11 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of delirium-coma-free days (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03002701, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in